Carnitine palmitoyltransferase
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | <StructureSection load='2rcu' size='350' side='right' scene='48/485614/ | + | <StructureSection load='2rcu' size='350' side='right' scene='48/485614/Cv1/1' caption='Rat carnitine palmitoyltransferase II dimer complex with substrate analog and octylglucoside (PDB code [[2rcu]])'> |
__TOC__ | __TOC__ | ||
== Function == | == Function == |
Revision as of 14:02, 13 February 2023
|
3D structures of carnitine palmitoyltransferase
Updated on 13-February-2023
2le3 – hCPT I regulatory domain – human - NMR
2m76 - hCPT I regulatory domain – NMR
2h4t, 2fyo, 2deb – rCPT II – rat
2fw3 - rCPT II + antidiabetic drug
2rcu – rCPT II + substrate analog
4ep9, 4eph, 4eyw - rCPT II + inhibitor
References
- ↑ Bonnefont JP, Djouadi F, Prip-Buus C, Gobin S, Munnich A, Bastin J. Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Aspects Med. 2004 Oct-Dec;25(5-6):495-520. PMID:15363638 doi:http://dx.doi.org/10.1016/j.mam.2004.06.004
- ↑ Rufer AC, Lomize A, Benz J, Chomienne O, Thoma R, Hennig M. Carnitine palmitoyltransferase 2: analysis of membrane association and complex structure with a substrate analog. FEBS Lett. 2007 Jul 10;581(17):3247-52. Epub 2007 Jun 8. PMID:17585909 doi:10.1016/j.febslet.2007.05.080